F.D.A. Rejects Closely Watched Lung Cancer Drug From China

New York Times - Nov 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read full article

More News

The Market Noise

The Market Noise is the first place to look when you need financial and economic insights. We deliver the most accurate news in the business and marketing world to you.

NEWSLETTER